(Press-News.org) Antonia Seligowski, PhD, of the Neurocardiac Effects of Stress & Trauma Laboratory within the Department of Psychiatry at Mass General Brigham, is the senior author of a paper published in JAMA Network Open, “Hormonal contraceptive use, stress disorders, and cardiovascular and thrombotic risk in women.”
Q: What challenges or unmet needs make this study important?
Over 400,000 women in the United States die each year from cardiovascular disease (CVD), the nation’s leading cause of death. Stress is a major risk factor for CVD, and stress‑related psychiatric disorders like anxiety and post-traumatic stress disorder (PTSD) are more common in women. Because of this, experts have called for more attention to be paid to sex‑specific factors that contribute to women’s cardiovascular health.
One such factor is hormonal contraception, used by about 9.1 million women in the United States. Past research on these contraceptives—which work by introducing different amounts of hormones and suppressing natural estradiol and progesterone levels—has focused almost entirely on young, relatively healthy women. As a result, very little is known about how hormonal contraceptives affect women with stress‑related psychiatric disorders. To our knowledge, this study is the first to examine the combined effects of hormonal contraceptives and stress‑related disorders on cardiovascular or thrombosis risk.
Q: What central question(s) were you investigating?
Our study, led by Jordan Thomas, PhD, of the University of Kansas, explored whether hormonal contraceptive use is linked to cardiovascular and thrombotic risk in women with and without stress‑related disorders. Specifically, we wanted to know if women with a history of depression, anxiety or PTSD who use hormonal contraceptives have a higher risk of major adverse cardiovascular events (MACE) or deep‑vein thrombosis than those without this mental health history.
Q: What methods or approach did you use?
We analyzed healthcare records from 31,824 women who consented to be part of the Mass General Brigham Biobank. Specifically, we looked for medical codes indicating diagnoses of stress‑related disorders, MACE and deep‑vein thrombosis, as well as prescriptions for hormonal contraceptives.
Q: What did you find?
For the majority of women, including those with a history of anxiety or depression, hormonal contraceptive use was associated with lower risk of MACE. However, this protective association was not seen in women with PTSD.
Although preliminary, these findings suggest that cardiovascular risk may vary among women who use hormonal contraceptives—especially differing for those with PTSD. If future studies confirm these results, clinicians may need to consider stress‑related psychiatric disorders when discussing hormonal contraceptive options with patients.
Q: Tell us about any follow-up studies you have planned to validate or build on these findings.
We hope to conduct a clinical study that collects new data on how specific hormonal contraceptive formulas relate to CVD risk factors in women, including blood pressure, vascular endothelial function and blood‑based clotting markers. We also plan to test whether these effects differ for women with and without stress‑related psychiatric disorders. Participants would return yearly for follow‑up visits to track clinical outcomes such as thrombotic events.
Authorship: In addition to Seligowski, Mass General Brigham authors include Robyn Ellis, Shady Abohashem, Anahita Dua, Emily Lau, Karen Miller, Rachel Rosovsky, Ahmed Tawakol and Michael Osborne.
Paper cited: Thomas, J., et al. “Hormonal contraceptive use, stress disorders, and cardiovascular and thrombotic risk in women.” JAMA Network Open. DOI: 10.1001/jamanetworkopen.2025.51878
Disclosures: Miller has received study medication and investigator-initiated research grants from Amgen and has equity in Bristol-Myers Squibb (BMS), General Electric, Boston Scientific and Becton Dickinson. Osborne receives consulting fees from WCG Clinical for unrelated work.
END
Research spotlight: Interplay of hormonal contraceptive use, stress and cardiovascular risk in women
2026-02-05
ELSE PRESS RELEASES FROM THIS DATE:
Pennington Biomedical’s Dr. Catherine Prater awarded postdoctoral fellowship from the American Heart Association
2026-02-05
BATON ROUGE, La. – Dr. Catherine Prater, postdoctoral researcher at Pennington Biomedical Research Center, has received a two-year fellowship from the American Heart Association. The fellowship includes a grant of more than $150,000 that will support research focused on weight gain markers. Her research project, “Examination of Metabolic Characteristics in the Predisposition for Weight Gain,” will reexamine existing clinical trial data with the goal of improving prediction ...
AI agents debate more effectively when given personalities and the ability to interrupt
2026-02-05
In a typical online meeting, humans don't always wait politely for their turn to speak. They interrupt to express strong agreement, stay silent when they are unsure, and let their personalities shape the flow of the discussion. Yet, when Artificial Intelligence (AI) agents are programmed to debate or collaborate, they are usually forced into a rigid, round-robin structure that stifles this natural dynamic.
Researchers from The University of Electro-Communications and the National Institute of Advanced Industrial Science and Technology (AIST) have demonstrated that allowing AI agents to break these rules can actually make them smarter.
Their new ...
Tenecteplase for acute non–large vessel occlusion 4.5 to 24 hours after ischemic stroke
2026-02-05
About The Study: Among patients with non–large vessel occlusion acute ischemic stroke and salvageable brain tissue, intravenous tenecteplase, a modified human tissue plasminogen activator, administered 4.5 to 24 hours after onset resulted in a greater likelihood of an excellent functional outcome at 90 days than standard care but had an increased risk of symptomatic intracranial hemorrhage.
Corresponding Author: To contact the corresponding author, Junwei Hao, MD, PhD, email haojunwei@vip.163.com.
To ...
Immune 'hijacking' predicts cancer evolution
2026-02-05
Predicting tumour progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE) and the Ludwig Institute for Cancer Research have discovered that neutrophils, a type of immune cell, undergo reprogramming when they come into contact with the tumour ecosystem and contribute to its progression. They then produce a molecule — the chemokine CCL3 — which promotes cancer growth rather than fighting it. This mechanism appears to be a major variable in tumour biology and could serve ...
VIP-2 experiment narrows the search for exotic physics beyond the Pauli exclusion principle
2026-02-05
The Pauli exclusion principle is a cornerstone of the Standard Model of particle physics and is essential for the structure and stability of matter. Now an international collaboration of physicists has carried out one of the most stringent experimental tests to date of this foundational rule of quantum physics and has found no evidence of its violation. Using the VIP-2 experiment, the team has set the strongest limits so far for possible violations involving electrons in atomic systems, significantly constraining a range of speculative theories beyond the Standard Model, including those that suggest electrons have internal structure, and so-called ‘Quon models.’ Their ...
A global challenge posed by the presence of pharmaceuticals in the environment
2026-02-05
Pharmaceutical products are essential for health, and they play and will continue to play a key role in disease prevention and treatment. However, they are exerting a major impact on the environment by affecting ecosystems and human health, and contributing to biodiversity loss, antimicrobial resistance and climate change. The main ingredients of medicines designed to achieve the desired health effect, together with their excipients (inert substances mixed with medicines to provide them with consistency, shape, taste, etc.) and packaging materials, are polluting the air, soil and water worldwide. This leads to problems in ecosystems, which then translate into an impact ...
Dream engineering can help solve ‘puzzling’ questions
2026-02-05
EVANSTON, Ill. --- We’ve all heard the best approach to solve a problem is to “sleep on it.” It turns out there may be more truth to this adage than previously thought. While stories abound of eureka moments surfacing from dreams, scientific evidence has remained elusive, due to the challenge of systematically manipulating dreams.
A new study by neuroscientists at Northwestern University validates the possibility of influencing dreams and offers a crucial step to support the theory that dreams in REM sleep — the rapid ...
Sport: ‘Football fever’ peaks on match day
2026-02-05
The mean stress level of fans of the football club Arminia Bielefeld was 41% higher on the day of the German Football Association’s (DFB-Pokal) 2025 Cup final compared to non-match days, according to a study published in Scientific Reports. The authors suggest that this reaction, known as ‘football fever’, may be driven by the intensity of fans’ emotions towards their ...
Scientists describe a window into evolution before the tree of life
2026-02-05
All life on Earth shares a common ancestor that lived roughly four billion years ago. This so-called “last universal common ancestor” represents the most ancient organism that researchers can study.
Previous research on the last universal common ancestor has found that all the characteristics we see in organisms today, like having a cell membrane and a DNA genome, were already present by the time of this ancestor. So, if we want to understand how these foundational characteristics of life first emerged, then we need to be able to study evolutionary history prior to the last universal common ancestor.
In a new article ...
Survival of patients diagnosed with cancer during the COVID-19 pandemic
2026-02-05
About The Study: This cohort study found that individuals diagnosed with cancer in 2020 and 2021 experienced worse short-term survival than those diagnosed between 2015 and 2019, suggesting substantial harms associated with cancer care disruptions during the first 2 years of the COVID-19 pandemic.
Corresponding Author: To contact the corresponding author, Todd Burus, PhD, email tburus@uky.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2025.6332)
Editor’s Note: Please ...